Product Images Valsartan

Pharma USA's Valsartan Tablets are available in a bottle of only 90 tablets. Each film-coated tablet contains 160 mg of Valsartan, USP. The product should be dispensed with the patient information leaflet. For dosage and administration, refer to the prescribing information. The product should be stored between 20°C to 25°C (68°F to 77°F) with occasional excursions to 15°C to 30°C (59°F to 86°F). Protect the product from moisture and dispense it in a tight container. This product was manufactured by Macleods Pharmaceuticals Ltd., Daman (U.T.), INDIA, for Macleods Pharma USA, Inc., Princeton, NJ 08540. The code number is DD/DRUGS/DD/375 and the GTIN is 00333342064103. The OPZ area is 45x16 mm.*

This package contains 3900 film-coated tablets of Valsartan, USP 160 mg. The tablets should be repackaged within six months from the date of manufacture and stored at 20°C to 25°C, with excursions permitted to 15°C to 30°C. The tablets should be protected from moisture and dispensed in a tight container. The package was manufactured by MACLEODS PHARMACEUTICALS LIMITED in Daman, India, and is intended for bulk shipment. The code number indicated is DD/DRUGS/DDI375, and the NDC number is 33342-064-79. Please handle the package carefully.*

This is a description of a medication package of Valsartan, USP 320 mg, coated tablets manufactured in India by Macleods Pharmaceuticals Ltd., and packaged by Legacy Pharmaceutical Packaging LLC in the United States. The tablets come in a container that holds 90 tablets and has an NDC number of 33342-065-10. The usual dose and the dosage and administration instructions can be found in the prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The package carries a warning to avoid moisture and dispenses in a tight container.*

This is a description of a medication called Valsartan, manufactured by Macleods Pharma USA, Inc. The medication is available in film-coated tablet form containing 320 mg Valsartan USP. The usual dosage of the tablet is advised to refer to prescribing information provided for dosage and administration. The medication needs to be stored at a temperature of 20° to 25°C (68° to 77°F) and should be kept from moisture. The provided code number is DD/DRUGS/DD/375. The size of the OPZ area is 40 x 32 mm. This text is useful for pharmacy workers who need to dispense this medication to patients.*

This is a medication with the NDC code 33342-065-80, containing Valsartan Tablet USP 320 mg. It comes in a bulk shipment and should be handled with care. The tablets must be repacked within 6 months from the date of manufacture. The medication should be stored at 20° to 25°C and protected from moisture. The manufacturer is Macleods Pharmaceuticals Limited in India. No further information is available.*

The text describes a medicine called Valsartan Tablets USP with a strength of 40 mg. This drug is dispensed along with a Patient Information Leaflet and has a total of 30 tablets per package. The usual dosage of this medication can be found in the Prescribing Information for Dosage and Administration. The tablets need to be stored at a temperature between 20 to 25 degrees Celsius and protected from moisture. The manufacturer of these tablets is Macleods Pharma USA, Inc. based in Princeton, NJ, and they are packaged by Packaging LLC. It also indicates the NDC number and other codes for identification purposes.*

This is a description of a prescription drug called Valsartan. It is a film-coated tablet with a dosage of 40mg. The recommended dosage and administration information can be found in the prescribing information. The tablets should be stored between 20°C to 25°C with excursions permitted to 15°C to 30°C. The drug should be protected from moisture and dispensed in a tight container. The manufacturer is Macleods Pharma USA, Inc. located in Princeton, NJ. The drug is manufactured by Macleods Pharmaceuticals Ltd in Daman, India.*

This is a bulk shipment of Valsartan Tablets, USP 40 mg containing 15600 tablets with the NDC number 33342-062-77 and code number DD/DRUGS/DD/375. The tablets should be repacked within 6 months from the date of manufacture and stored between 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) to protect from moisture. The manufacturer is Macleods Pharmaceuticals Limited located in Daman (U.T.) India. The text contains no non-English characters.*

Pharma USA's Valsartan Tablets in USP contain 80mg of Valsartan. The drug is meant for dispensing with the Patient Information Leaflet. It comes in a tightly packaged container with 90 film-coated tablets, and store it between 20°C to 25°C, with permitted excursions to 15°C to 30°C. It is critical to protect from moisture. Dispensing information and dosage prescription should consult a doctor. The product is manufactured by Macleods Pharmaceuticals in Daman (U.T.), India, and packaged by Legacy Pharmaceutical Packaging LLC in Earth City, MO.*

This is a pharmacy label of Valsartan tablets which are used for treating hypertension and heart failure. The label displays the dosage, 90 tablets containing 80mg of Valsartan USP, instructions to check the patient information leaflet and prescription, and a manufacturer's statement with its address and code. It also gives the usual dosage, storage temperature, and its protection guidelines.*

This is a bottle of Valsartan Tablets, USP 80mg for repackaging purposes only. The bottle contains 7800 film-coated tablets and must be repacked within 6 months from the date of manufacture. The tablets must be stored at a temperature between 20 to 25 °C (68 ° to 77°F) with some variations permitted between 15° to 30°C (59° to 86°F). The drug is manufactured by Macleods Pharmaceuticals Limited in Daman, India. The NDC number is 33342-063-78.*

This appears to be a table comparing the effectiveness of Valsartan and Captopril in different subgroups of patients based on age, gender, race, location, and usage of beta-blocker medication. The table shows the number of patients in each subgroup and whether Valsartan or Captopril was more effective in each group.*